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the Sepsis-3 defines sepsis as a life-threatening organ dysfunction due to dysregulated 
host response to infection. Septic shock occurs in patients with sepsis and it is a high 
mortality acute syndrome characterized by impaired distribution of microvascular blood 
flow and cellular dysoxia. It is defined by persisting hypotension requiring vasopressors 
to maintain a mean arterial blood pressure (BP) greater than 65 mmHg and a serum 
lactate level greater than 2 mmol/L despite adequate volume resuscitation. 
The genus Cupriavidus refers to an ubiquitous, Gram-negative, aerobic, non fermenting, 
non spore forming bacilli tipically distributed in environmental habitats. Cupriavidus 
pauculus has been implicated in the majority of the infections [1] but few cases are 
reported in the literature. 
In November 2017, a 48-year-old woman with obesity and hypertension was referred to 
our hospital because of a diagnosis of acute myelomonocytic leukemia. 
A central line was placed and a chemotherapy regimen 7+3 with Cytarabine/Idarubicin 
was started. 
On hospital day 9 the patient became hypotensive, tachycardic, tachypneic, febrile and 
oligoanuric. Blood gas analysis showed compensated metabolic acidosis and 
hyperlactacidemia. Biochemistry was consistent with aplastic phase following 
chemotherapy. Due to maintain a mean BP lower than 65 mmHg after crystalloid 
resuscitation, norepinefrine was started. 
Two pairs of aerobic and anaerobic blood cultures, drawn through the central venous 
catheter, were performed and Meropenem (1 g every 8 h), Vancomycin (1 g every 12 h) 
and Caspofungin (50 mg every 24 h) were started. 
After 24 h, Gram staining showed gram negative rods in the aerobic blood cultures. 
Vancomycin and Caspofungin were stopped and the central line was removed. 
After 48 h, round and smooth colonies, catalase and oxidase positive grew on blood 
agar plates and non-lactose-fermenter colonies grew on MacConkey agar plates. 
Microscan Walkaway 96 Plus (Beckman Coulter) and Phoenix (Becton Dickinson) 
automated system were not able to identify the isolated agent. 
Identification of C. pauculus (confidence values of 99.9%) was performed with Matrix-
assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry 
(VITEK MS system- BioMérieux). 
The isolate subsequently underwent 16S rRNA gene sequencing that identified C. 
pauculus (100% match with C. pauculus strain CIP 105943, GenBank accession no NR 
116147). 
The in vitro susceptibility of the isolate was assessed with Etest. Colistin was tested by 
means of a broth microdiluition system. Results are reported in the Table. 
Following the results of susceptibility testing, Ciprofloxacin (400 mg every 12 h) was 
added to Meropenem and antimicrobial therapy was continued for 10 days. We decided 
to add Ciprofloxacin to Meropenem because we are not comfortable with suspending 
Meropenem and de-escalate antimicrobial therapy due to possibility of undetected 
coinfection.  
Molecular genetic assay did not identify carbapenemase genes KPC, OXA, VIM, IMP, 
NDM. 
Patient was discharged on day 28 in good clinical condition and she is still being 
followed in Hematology out-patient clinic. 
In order to avoid C. pauculus outbreaks, enviromental survey was performed in the 
wards to which the patient had been admitted and it was negative. 
Previously known as CDC group IVc-2, Ralstonia and later Wautersia, the genus 
Cupriavidus contains 13 species. C. pauculus can induce infection in 
immunocompromised as well as in immunocompetent individuals, in community or 
nosocomial setting. It can cause bacteremia, pneumonia, meningitis, intravascular 
catheter and medical devices bloodstream infections [1-8].  
The incidence of Cupriavidus spp. infections may be underreported due to 
misidentification on actual automated laboratory platforms.  
Recent introduction of  MALDI-TOF mass spectrometry improved the possibilities to 
phenotypically identify this unusual pathogen. 
Few data are reported about antimicrobial susceptibility. Wide susceptibility to 
fluoroquinolones, Ceftazidime and Imipenem had been observed [1].  
Resistance to Carbapenems had been described. Karafin et al. reported a case of 
Meropenem and Imipenem resistant C. gilardii bacteremia [6]. Salar et al. described a 
case of Imipenem resistant C. pauculus bacteremia [7]. Uzodi et al. reported a 
Meropenem resistant C. pauculus bacteremia in a child on extracorporeal membrane 
oxygenation [2]. Few data about Colistin minimal inhibitory concentration (MIC) are 
reported too. Aydin et al. [3] and Dan et al. [8] described two cases with Colistin 
susceptibility. Conversely, Vay et al. [4] reported a Meropenem and Imipenem 
susceptible C. pauculus bacteremia with Colistin MIC 2 µg/mL. 
Optimal regimen for therapy of C. pauculus is not known and specific clinical 
breakpoints are lacking. D’Inzeo et al.  [1] and Langevin et al. [5] interpreted C. 
metallidurans susceptibility according to Clinical and Laboratory Standards Institute 
(2013) breakpoints for Pseudomonas aeruginosa. According to Pseudomonas spp. 
European Committee on Antimicrobial Susceptibility Testing Clinical Breakpoint 
(2018) C. pauculus strain isolated in our patient is resistant to Meropenem (MIC 
Breakpoint: R >2) and Colistin (MIC Breakpoint: R >2). 
We report the first case of septic shock caused by Meropenem and Colistin resistant C. 
pauculus. 
C. pauculus is able to cause severe infections in humans and to easily gain antimicrobial 
resistance presenting a susceptibility profile not far to a multidrug resistant agent. 
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